Down 30% From Its High, Is SpaceX Stock a Buy Now?

The article argues SpaceX (SPCX) is significantly overvalued, citing a $2.08T market cap vs. 111x 2025 sales ($18.7B revenue) and 56x forward 2026 sales ($36.9B consensus). It notes SpaceX posted a large net loss of $4.3B in 2025, while profitability is concentrated in Starlink (most profitable segment). Despite a modest rebound, the stock remains ~30% below its all-time high, with the author recommending investors wait for multiple quarters of earnings confirmation.

Analysis

The real market signal here is not about one private name’s valuation; it is about how much of the Musk complex is still being supported by narrative rather than verifiable cash flow. That matters most for TSLA, because any reset in investor willingness to pay for “platform optionality” tends to hit the most crowded proxy first, even if the underlying fundamentals are unchanged. In other words, this is more a multiple-risk event than an operating-risk event.

The immediate catalyst path is sentiment-driven and can persist for days to weeks, especially if there is another capital raise, secondary, or any disclosure that makes the funding stack look more dependent on external markets. Over 1-3 months, the key watch item is whether growth is merely decelerating from hypergrowth to strong growth; if so, the valuation framework shifts from venture-style to public-equity-style, which should compress the premium materially. The 6-18 month issue is that once a business is priced at extreme sales multiples, even modest execution misses can erase years of expected upside.

The contrarian view is that the market may still be underestimating the strategic value of embedded distribution and network effects, but that optionality deserves a discount until audited segment economics prove the take rate and retention are durable. The best risk/reward is not to chase the private name, but to fade the nearest liquid expression of the same psychology. If the market keeps rotating away from speculative duration, profitable high-growth names should outperform the Musk complex.

Key Decisions for Investors

• Short TSLA on strength over the next 1-3 weeks as the cleanest liquid proxy for a Musk-premium de-rating; cover if it reclaims prior highs on improving auto/FCF guidance or if sentiment in large-cap growth re-accelerates.
• Pair trade: long NVDA / short TSLA for 1-3 months to express quality-growth vs narrative-growth; NVDA has the balance-sheet and earnings visibility to absorb a duration selloff better than TSLA.
• If a SpaceX secondary or new financing surfaces, treat it as a catalyst to add to TSLA short exposure rather than chase the private name; that event would confirm valuation is still financing-dependent.
• Watch for any 1-2 quarter slowdown in Starlink-style growth metrics; that would be the key falsifier for the overvaluation thesis and would justify covering growth-fade shorts.